CA19-9, CA242, CEA, and other tumor markers and P53 levels can be used as important indicators to evaluate the patient’s condition and prognosis, and provide an important theoretical basis for clinical evaluation and treatment of patients’ prognosis. This evidence concerns the gene CEACAM5 and neoplasm.